AU2001238143A1 - Tumor suppressor gene, p47ing3 - Google Patents

Tumor suppressor gene, p47ing3

Info

Publication number: AU2001238143A1
Authority: AU; Australia
Prior art keywords: p47ing3; tumor suppressor; suppressor gene; gene; tumor
Prior art date: 2000-02-09
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2001238143A

Inventor

Curtis C. Harris

Makoto Nagashima

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

US Department of Health and Human Services

Original Assignee

US Department of Health and Human Services

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-02-09

Filing date

2001-02-09

Publication date

2001-08-20

2001-02-09 Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services

2001-08-20 Publication of AU2001238143A1 publication Critical patent/AU2001238143A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
General Health & Medical Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Medicinal Chemistry (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Analytical Chemistry (AREA)
Pathology (AREA)
Toxicology (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Gastroenterology & Hepatology (AREA)
Microbiology (AREA)
Oncology (AREA)
Hospice & Palliative Care (AREA)
Physics & Mathematics (AREA)
Biotechnology (AREA)
Wood Science & Technology (AREA)
General Physics & Mathematics (AREA)
Food Science & Technology (AREA)
Cell Biology (AREA)
General Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Peptides Or Proteins (AREA)

AU2001238143A 2000-02-09 2001-02-09 Tumor suppressor gene, p47ing3 Abandoned AU2001238143A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US18129200P	2000-02-09	2000-02-09
US60/181,292		2000-02-09
PCT/US2001/004425 WO2001059114A2 (en)	2000-02-09	2001-02-09	Tumor suppressor gene, p47ing3

Publications (1)

Publication Number	Publication Date
AU2001238143A1 true AU2001238143A1 (en)	2001-08-20

Family

ID=22663657

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2001238143A Abandoned AU2001238143A1 (en)	2000-02-09	2001-02-09	Tumor suppressor gene, p47ing3

Country Status (3)

Country	Link
US (5)	US7335749B2 (en)
AU (1)	AU2001238143A1 (en)
WO (1)	WO2001059114A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1366073A2 (en) *	2001-02-27	2003-12-03	PE Corporation (NY)	Isolated human tumor supressor proteins, nucleic acid molecules encoding these human tumor supressor proteins, and uses thereof
WO2003062398A2 (en) *	2002-01-23	2003-07-31	The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	NEW TUMOR SUPPRESSOR GENE, p28ING5

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US121891A (en) *		1871-12-12		Improvement in steam-engines
US6117633A (en) *	1995-12-08	2000-09-12	University Technologies International Inc.	DNA sequence encoding the tumor suppressor gene ING1
US6297366B1 (en) *	1998-01-14	2001-10-02	Board Of Trustees Of The University Of Illinois	ING-encoded p33ING1 protein as a mediator of p53 signaling pathway in mammalian cells
CA2383592A1 (en)	1999-03-31	2000-10-05	Curagen Corporation	2384891 acids including open reading frames encoding polypeptides; orfx
US20050048623A1 (en) *	1999-07-21	2005-03-03	Incyte Corporation	Cell cycle and proliferation proteins
EP1196577A2 (en)	1999-07-21	2002-04-17	Incyte Genomics, Inc.	Cell cycle and proliferation proteins
AU7680300A (en) *	1999-08-18	2001-03-13	Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Forschung E.V.	Human dna sequences
US6569662B1 (en) *	2000-01-21	2003-05-27	Hyseq, Inc.	Nucleic acids and polypeptides

2001
- 2001-02-09 AU AU2001238143A patent/AU2001238143A1/en not_active Abandoned
- 2001-02-09 US US10/203,532 patent/US7335749B2/en not_active Expired - Fee Related
- 2001-02-09 WO PCT/US2001/004425 patent/WO2001059114A2/en not_active Ceased
2007
- 2007-12-21 US US11/962,906 patent/US7709609B2/en not_active Expired - Fee Related
2010
- 2010-03-15 US US12/724,305 patent/US8067563B2/en not_active Expired - Fee Related
2011
- 2011-10-11 US US13/271,026 patent/US8415097B2/en not_active Expired - Fee Related
2013
- 2013-04-08 US US13/858,807 patent/US8957015B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US20130302800A1 (en)	2013-11-14
US7335749B2 (en)	2008-02-26
WO2001059114A2 (en)	2001-08-16
US8957015B2 (en)	2015-02-17
WO2001059114A9 (en)	2002-10-24
US8067563B2 (en)	2011-11-29
US20040058379A1 (en)	2004-03-25
WO2001059114A3 (en)	2002-03-07
US8415097B2 (en)	2013-04-09
US20100323351A1 (en)	2010-12-23
US7709609B2 (en)	2010-05-04
US20080171854A1 (en)	2008-07-17
US20120064524A1 (en)	2012-03-15

Publication	Publication Date	Title
AU2001280796A1 (en)	2002-02-05	Electrowetting-driven micropumping
AU2002313559A1 (en)	2003-03-10	Genes
AU2002259196A1 (en)	2003-03-03	Gene expression profiling
AU2002211835A1 (en)	2002-04-08	Oncology tissue microarrays
AU5215601A (en)	2001-09-17	Inflammation-related gene
AU2002221927A1 (en)	2002-06-18	Electrospray interface
AU6594401A (en)	2001-12-03	6-heterocyclyl-3-oxo-3,4-dihydro-quinoxalines
AU2001242625A1 (en)	2001-10-08	Gene sequence
AU2001295777A1 (en)	2002-05-06	Target
AU2001265096A1 (en)	2001-12-03	Short-root gene, promoter, and uses thereof
AU2001264247A1 (en)	2002-03-14	GASC1 gene
AU2002240466A1 (en)	2002-09-12	Hin-1, a tumor suppressor gene
AU2002225178A1 (en)	2002-07-30	Gene silencing suppressor
AU2001240103A1 (en)	2001-09-17	Reproduction-specific genes
AU2001277857A1 (en)	2002-01-21	Tumor necrosis factor-gamma
AUPQ749100A0 (en)	2000-06-08	New epilespy gene
AU2001247444A1 (en)	2001-09-24	Erbeta-mediated gene expression
AU2001285743A1 (en)	2001-12-24	Adipose-related gene
AU7567101A (en)	2001-11-26	Gene expression system
AU2001238143A1 (en)	2001-08-20	Tumor suppressor gene, p47ing3
AUPQ980600A0 (en)	2000-09-21	Tumour suppressor gene
AU6017900A (en)	2001-05-14	Novel tumor suppressor gene
AU2003209370A1 (en)	2003-09-02	New tumor suppressor gene, p28ing5
AU2879199A (en)	1999-09-15	Dlc-1 gene, a putative tumors suppressor gene
AU2176401A (en)	2001-06-04	ILK-2, an integtrin-linked kinase